Clinical Trials
24 trialsDasatinib in Combination With Bevacizumab to Treat Advanced Solid Tumors
National Institutes of Health Clinical Center (CC)
Phase I Trial of 4'-Thio-2'-Deoxycytidine (TdCyd) in Patients With Advanced Solid Tumors
National Institutes of Health Clinical Center (CC)
Distraction-Based Interventions During Implanted Venous Port Catheter Needle Entry: Virtual Reality Application
Uludag University
Yoga to Improve Disparities in Cancer Survivorship
University of California, San Francisco
Development and Validation of a Multimodal Fusion Artificial Intelligence Model for Predicting the Efficacy of Neoadjuvant Treatment of Bladder Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Patient Navigation 2.0
Northwestern University
EORTC
Sohag Oncology Center
Combination Nilotinib and Paclitaxel in Adults With Relapsed Solid Tumors
National Institutes of Health Clinical Center (CC)
Novel Single Wave Assessment in Measuring Cardiac Dysfunction and Metabolic Syndrome in Patients With Cancer
City of Hope Medical Center
Immunotherapy Combination: Irradiated PD-L1 CAR-NK Cells Plus Pembrolizumab Plus N-803 for Subjects With Recurrent/Metastatic Gastric or Head and Neck Cancer
National Institutes of Health Clinical Center (CC)
First-in-human Single Agent Study of SAR442257 in RRMM and RR-NHL
Sanofi
Machine Learning to Analyze Facial Imaging, Voice and Spoken Language for the Capture and Classification of Cancer/Tumor Pain
National Institutes of Health Clinical Center (CC)
Cabozantinib in Combination With 13-cis-Retinoic Acid in Children With Relapsed or Refractory Solid Tumors
University of California, San Diego
Spanish Meaning-Centered Psychotherapy for Cancer
University of Valencia
PIPO
Vall d'Hebron Institute of Oncology
ARMOR
University of California, San Francisco
Bright IDEAS - Young Adults Problem-Solving Skills Training
Rutgers, The State University of New Jersey
Supportive Oncology Care at Home Post-Discharge
Massachusetts General Hospital
CEICS
Chulabhorn Cancer Center
Phase 1 Trial of LVGN6051 as Single Agent and in Combination With Keytruda (Pembrolizumab) in Advanced or Metastatic Malignancy
Lyvgen Biopharma Holdings Limited
Phase 1 Trial of LVGN7409 (CD40 Agonist Antibody) as Single Agent and Combination Therapies in Advanced or Metastatic Malignancy
Lyvgen Biopharma Holdings Limited
Genetic Analysis in Identifying Late-Occurring Complications in Childhood Cancer Survivors
Children's Oncology Group
Meraki_Cancer
University of Valencia
Laughter Yoga Effect on Cancer Patients' Physiopsychological Symptoms
Ataturk University